Anti-LSS monoclonal antibody

Pre-made anti-LSS monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to LSS/LSS products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T56175-Ab-1/ GM-Tg-hg-T56175-Ab-2Anti-Human LSS monoclonal antibodyHuman
GM-Tg-rg-T56175-Ab-1/ GM-Tg-rg-T56175-Ab-2Anti-Rat LSS monoclonal antibodyRat
GM-Tg-mg-T56175-Ab-1/ GM-Tg-mg-T56175-Ab-2Anti-Mouse LSS monoclonal antibodyMouse
GM-Tg-cynog-T56175-Ab-1/ GM-Tg-cynog-T56175-Ab-2Anti-Cynomolgus/ Rhesus macaque LSS monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T56175-Ab-1/ GM-Tg-felg-T56175-Ab-2Anti-Feline LSS monoclonal antibodyFeline
GM-Tg-cang-T56175-Ab-1/ GM-Tg-cang-T56175-Ab-2Anti-Canine LSS monoclonal antibodyCanine
GM-Tg-bovg-T56175-Ab-1/ GM-Tg-bovg-T56175-Ab-2Anti-Bovine LSS monoclonal antibodyBovine
GM-Tg-equg-T56175-Ab-1/ GM-Tg-equg-T56175-Ab-2Anti-Equine LSS monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T56175-Ab-1/ GM-Tg-hg-T56175-Ab-2; GM-Tg-rg-T56175-Ab-1/ GM-Tg-rg-T56175-Ab-2;
GM-Tg-mg-T56175-Ab-1/ GM-Tg-mg-T56175-Ab-2; GM-Tg-cynog-T56175-Ab-1/ GM-Tg-cynog-T56175-Ab-2;
GM-Tg-felg-T56175-Ab-1/ GM-Tg-felg-T56175-Ab-2; GM-Tg-cang-T56175-Ab-1/ GM-Tg-cang-T56175-Ab-2;
GM-Tg-bovg-T56175-Ab-1/ GM-Tg-bovg-T56175-Ab-2; GM-Tg-equg-T56175-Ab-1/ GM-Tg-equg-T56175-Ab-2
Products NameAnti-LSS monoclonal antibody
Formatmab
Target NameLSS
Protein Sub-locationIntrocelluar Protein
Category of antibodyTherapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-LSS monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T56175-Ag-1Recombinant multi-species LSS/ CTRCT44/ OSC protein
    ORF Viral VectorvGMAAV000025human LSS AAV particle
    ORF Viral VectorpGMAAV000025human LSS AAV plasmid
    ORF Viral VectorpGMLPm004817mouse Lss Lentivirus plasmid
    ORF Viral VectorvGMLPm004817mouse Lss Lentivirus particle


    Target information

    Target IDGM-T56175
    Target NameLSS
    Gene ID4047,16987,81681,709227,491611,101080651,615906,100055292
    Gene Symbol and Synonyms2810025N20Rik,APMR4,CTRCT44,D10Ertd116e,HYPT14,LSS,OSC
    Uniprot AccessionP48449,P48450,P84466
    Uniprot Entry NameLSS_HUMAN,LSS_RAT,LSS_BOVIN
    Protein Sub-locationIntrocelluar Protein
    CategoryTherapeutics Target
    DiseaseN/A
    Gene EnsemblENSG00000160285
    Target ClassificationN/A

    The target: LSS, gene name: LSS, also named as CTRCT44, OSC. The protein encoded by this gene catalyzes the conversion of (S)-2,3 oxidosqualene to lanosterol. The encoded protein is a member of the terpene cyclase/mutase family and catalyzes the first step in the biosynthesis of cholesterol, steroid hormones, and vitamin D. Alternative splicing results in multiple transcript variants encoding different isoforms.[provided by RefSeq, Feb 2009].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.